TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells (Q40043701)
Jump to navigation
Jump to search
scientific article published on 15 February 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells |
scientific article published on 15 February 2007 |
Statements
1 reference
TGFbeta2 and TbetaRII are valid molecular biomarkers for the antiproliferative effects of tamoxifen and tamoxifen metabolites in breast cancer cells (English)
1 reference
Miriam B Buck
1 reference
Janet K Coller
1 reference
Thomas E Mürdter
1 reference
Michel Eichelbaum
1 reference
Cornelius Knabbe
1 reference
15 February 2007
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference